Eledon Pharmaceuticals Inc (NASDAQ: ELDN) is 22.71% higher on its value in year-to-date trading and has touched a low of $2.30 and a high of $5.54 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ELDN stock was last observed hovering at around $3.06 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $3.08, the stock is 7.71% and 2.80% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.19 million and changing 0.65% at the moment leaves the stock -14.68% off its SMA200. ELDN registered -25.24% loss for a year compared to 6-month loss of -25.60%. The firm has a 50-day simple moving average (SMA 50) of $2.9962 and a 200-day simple moving average (SMA200) of $3.6099.
The stock witnessed a -2.84% gain in the last 1 month and extending the period to 3 months gives it a -6.95%, and is 12.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.03% over the week and 6.28% over the month.
Eledon Pharmaceuticals Inc (ELDN) has around 31 employees, a market worth around $184.44M and $0.00M in sales. Distance from 52-week low is 33.91% and -44.40% from its 52-week high. The company has generated returns on investments over the last 12 months (-36.12%).
The EPS is expected to shrink by -18.67% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
95.0 institutions hold shares in Eledon Pharmaceuticals Inc (ELDN), with institutional investors hold 69.17% of the company’s shares. The shares outstanding are 59.88M, and float is at 55.34M with Short Float at 2.40%. Institutions hold 68.20% of the Float.
The top institutional shareholder in the company is BVF INC/IL with over 6.29 million shares valued at $16.61 million. The investor’s holdings represent 14.8853 of the ELDN Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 2.34 million shares valued at $6.17 million to account for 5.5253 of the shares outstanding. The other top investors are ZIMMER PARTNERS, LP which holds 2.11 million shares representing 4.99 and valued at over $5.57 million, while SCHONFELD STRATEGIC ADVISORS LLC holds 3.5479 of the shares totaling 1.5 million with a market value of $3.96 million.
